Menopause hormone therapy gets fresh look from regulators
The FDA has long-mandated so-called "black box" labels on hormone therapy for menopause, warning about stroke, blood clots dementia and breast cancer. But now, regulators are considering removing some of those warnings. Nikki Battiste has more.
The FDA has long-mandated so-called "black box" labels on hormone therapy for menopause, warning about stroke, blood clots dementia and breast cancer. But now, regulators are considering removing some of those warnings. Nikki Battiste has more.
What's Your Reaction?
